Journal article
Formoterol Compared with Beclomethasone and Placebo on Allergen-induced Asthmatic Responses
Abstract
Formoterol is a new long-acting beta 2-agonist. We compared the protective effect of 24 micrograms formoterol with 200 micrograms beclomethasone and placebo on inhaled allergen-induced asthmatic responses in mild stable asthmatic subjects. We measured airflow rates, histamine airway responsiveness, cell counts from sputum and peripheral blood, and markers of lymphocyte and eosinophil activation. Adjustments were made for the confounding effect …
Authors
Wong BJ; Dolovich J; Ramsdale EH; O'Byrne P; Gontovnick L; Denburg JA; Hargreave FE
Journal
American Journal of Respiratory and Critical Care Medicine, Vol. 146, No. 5_pt_1, pp. 1156–1160
Publisher
American Thoracic Society
Publication Date
November 1992
DOI
10.1164/ajrccm/146.5_pt_1.1156
ISSN
1073-449X
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AdultAirway ResistanceAsthmaBeclomethasoneBlood Cell CountBlood ProteinsBronchial Provocation TestsBronchoconstrictionBronchodilator AgentsConfounding Factors, EpidemiologicEosinophil Granule ProteinsEosinophilsEthanolaminesFemaleForced Expiratory VolumeFormoterol FumarateHistamineHumansHypersensitivityLymphocyte ActivationMaleReceptors, Interleukin-2RibonucleasesSputum